SOD1 and metabolic dysfunction-associated steatotic liver disease: Interestingly, total SOD activity as well as SOD2 activity, were reported to be decreased, whereas SOD1 activity was shown to have increased in a mouse MASLD model as compared to controls (Wu et al. 2015).